Thrombophilic risk factors in patients with
central retinal vein occlusion.
Conclusion: Radial optic neurotomy improved both the visual function and macular edema in ischemic
central retinal vein occlusion.
Central Retinal Artery Equivalent and
Central Retinal Vein Equivalent were explored to meet the challenge raised in the study of retinal vascular dimension when retinal microvascular anatomy has been found different in different individuals [72].
Conforto, "The Natural Course of
Central Retinal Vein Occlusion" Ophthalmology, vol.
Ho et al., "Therapies for macular edema associated with
central retinal vein occlusion: a report by the American Academy of Ophthalmology," Ophthalmology, vol.
Late hyperbaric oxygen treatment of cilioretinal artery occlusion with nonischemic
central retinal vein occlusion secondary to high altitude.
Azad, "Case report: bilateral simultaneous
central retinal vein occlusion in Waldenstroom's macroglobulinemia," Optometry, vol.
CRVO is caused by a circulatory disturbance at the trunk of the
central retinal vein near the lamina cribrosa.
*
Central retinal vein occlusion (CRVO) has various etiologies, mostly because of hypercoagulopathies or cardiovascular diseases.
Intravitreal triamcinolone acetonide treatment of macular edema associated with
central retinal vein occlusion.
Specifically designed for the eye and proven to save sight, ranibizumab is indicated for the treatment of neovascular wet age-related macular degeneration (wet AMD), visual impairment due to DME and due to macular edema secondary to both branch retinal vein occlusion (BRVO) and
central retinal vein occlusion (CRVO); and visual impairment due to choroidal neovascularization (CNV) secondary to pathologic myopia (myopic CNV).
Outside the U.S., Lucentis is approved in more than 100 countries to treat patients with wet AMD, for the treatment of DME, and due to macular edema secondary to both branch retinal vein occlusion (BRVO) and
central retinal vein occlusion (CRVO).
